Clinical investigation of therapeutic effects of sorafenib on cutaneous angiosarcoma
Not Applicable
- Conditions
- Angiosarcoma
- Registration Number
- JPRN-UMIN000017373
- Lead Sponsor
- Taku Fujimura
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 2
Inclusion Criteria
Not provided
Exclusion Criteria
Possess the allergic reaction against sorafenib. Respilatory failure Interstitial pneumonia gastrointestinal hemorrhage cerebral hemorrhage
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Antitumor effect
- Secondary Outcome Measures
Name Time Method